Advertisement

Index by author

September 01, 1982; Volume 222,Issue 3

A

  1. Abiko, Y

    1. Effect of diltiazem, a calcium antagonist, on myocardial pH in ischemic canine heart.
      K Ichihara and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 720-725;

  2. Abramson, F P

    1. Interactions of phenobarbital with propranolol in the dog. 1. Plasma protein binding.
      S A Bai and F P Abramson
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 589-594;

  3. Anderson, W

    1. Analysis of the 2-deoxy-D-glucose-induced vagal stimulation of gastric secretion and gastrin release in dogs using methionine-enkephalin, morphine and naloxone.
      W Anderson, E Molina, J Rentz and B I Hirschowitz
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 617-622;

  4. Antonaccio, M J

    1. Pharmacological studies on sympathoinhibition produced by the medial medullary depressor region: proposed gamma-aminobutyric acid involvement in inhibition of somatosympathetic reflexes.
      D G Taylor, K A Taylor and M J Antonaccio
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 517-525;

  5. Ashizawa, H

    1. Central vasopressor responses to conjugated estrogens in rats may be mediated via a renin-angiotensin system in the brain.
      H Takahashi, H Ashizawa, K U Takeda, S Yoneda, M Yoshimura and H Ijichi
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 726-730;

B

  1. Bai, S A

    1. Interactions of phenobarbital with propranolol in the dog. 1. Plasma protein binding.
      S A Bai and F P Abramson
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 589-594;

  2. Barnes, G A

    1. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, A Grignolo, W L Whitmore, L Lerea, P A Trepanier, G A Barnes, S J Weigel, F J Seidler and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 746-751;
    2. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, F J Seidler, P A Trepanier, W L Whitmore, L Lerea, G A Barnes, S J Weigel and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 741-745;

  3. Bartolome, J

    1. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, A Grignolo, W L Whitmore, L Lerea, P A Trepanier, G A Barnes, S J Weigel, F J Seidler and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 746-751;
    2. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, F J Seidler, P A Trepanier, W L Whitmore, L Lerea, G A Barnes, S J Weigel and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 741-745;

  4. Billingsley, M L

    1. Effects of DNA synthesis inhibitors on post-traumatic glial cell proliferation.
      M L Billingsley and H G Mandel
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 765-770;

  5. Blaker, W D

    1. Inhibition of acetylcholine turnover rate in rat hippocampus and cortex by intraventricular injection of adenosine analogs.
      T F Murray, W D Blaker, D L Cheney and E Costa
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 550-554;

  6. Brunswick, D J

    1. Effect of treatment of rats with antidepressants on melatonin concentrations in the pineal gland and serum.
      W E Heydorn, D J Brunswick and A Frazer
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 534-543;

  7. Brusilow, S

    1. Benzoate-induced changes in glycine and urea metabolism in patients with chronic renal failure.
      W E Mitch and S Brusilow
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 572-575;

  8. Buccafusco, J J

    1. Mechanism of the clonidine-induced protection against acetylcholinesterase inhibitor toxicity.
      J J Buccafusco
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 595-599;

  9. Buck, J D

    1. Role of autoregulation in the beneficial action of propranolol on ischemic blood flow distribution and stenosis severity in the canine myocardium.
      G J Gross, J D Buck, D C Warltier and H F Hardman
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 635-640;

C

  1. Cavero, I

    1. Pharmacological evidence favoring a similarity between alpha adrenoceptors mediating sleep in chicks and cardiac presynaptic alpha-2 receptors in rats.
      A G Roach, F Lefèvre-Borg, R Gomeni and I Cavero
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 680-687;

  2. Chan, C C

    1. Termination of responses to sympathetic nerve stimulation and to noradrenaline in a perfused arterial preparation: the role of neuronal and extraneuronal uptake.
      C C Chan and S Kalsner
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 731-740;

  3. Chassaing, C

    1. Mechanism of action of quinidine on heart rate in the dog.
      C Chassaing, P Duchene-Marullaz and M Paire
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 688-693;

  4. Chau, T T

    1. Evidence for the existence of peptide and nonpeptide morphine-like materials in mouse brain: effect of an analgesic intracerebroventricular dose of acetylcholine on their levels.
      T T Chau, C Izazola-Conde and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 612-616;

  5. Cheney, D L

    1. Inhibition of acetylcholine turnover rate in rat hippocampus and cortex by intraventricular injection of adenosine analogs.
      T F Murray, W D Blaker, D L Cheney and E Costa
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 550-554;

  6. Cherian, M G

    1. Chelation of cadmium from metallothionein in vivo and its excretion in rats repeatedly injected with cadmium chloride.
      M G Cherian and K Rodgers
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 699-704;

  7. Conanan, L B

    1. Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.
      D J Crutchley, L B Conanan and J R Maynard
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 544-549;

  8. Costa, E

    1. Inhibition of acetylcholine turnover rate in rat hippocampus and cortex by intraventricular injection of adenosine analogs.
      T F Murray, W D Blaker, D L Cheney and E Costa
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 550-554;

  9. Crutchley, D J

    1. Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.
      D J Crutchley, L B Conanan and J R Maynard
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 544-549;

D

  1. Dailey, J W

    1. Effect of increments in norepinephrine concentrations on seizure intensity in the genetically epilepsy-prone rat.
      K H Ko, J W Dailey and P C Jobe
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 662-669;

  2. de Jonge, A

    1. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. I. Central hypotensive and peripheral hypertensive activities.
      A de Jonge, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 705-711;
    2. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. II. Central and peripheral bradycardic activities.
      A de Jonge, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 712-719;

  3. Dewey, W L

    1. Evidence for the existence of peptide and nonpeptide morphine-like materials in mouse brain: effect of an analgesic intracerebroventricular dose of acetylcholine on their levels.
      T T Chau, C Izazola-Conde and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 612-616;

  4. Duchene-Marullaz, P

    1. Mechanism of action of quinidine on heart rate in the dog.
      C Chassaing, P Duchene-Marullaz and M Paire
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 688-693;

  5. Duckles, S P

    1. Cerebral blood vessels: effects of exogenous acetylcholine and field stimulation on norepinephrine release.
      S P Duckles and C D Kennedy
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 562-565;

  6. Duman, R

    1. Influence of adrenocorticotropin hormone and yohimbine on antidepressant-induced declines in rat brain neurotransmitter receptor binding and function.
      D A Kendall, R Duman, J Slopis and S J Enna
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 566-571;

E

  1. Enna, S J

    1. Influence of adrenocorticotropin hormone and yohimbine on antidepressant-induced declines in rat brain neurotransmitter receptor binding and function.
      D A Kendall, R Duman, J Slopis and S J Enna
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 566-571;

  2. Erickson, R R

    1. The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats.
      M Tsuru, R R Erickson and J L Holtzman
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 658-661;

F

  1. Frazer, A

    1. Effect of treatment of rats with antidepressants on melatonin concentrations in the pineal gland and serum.
      W E Heydorn, D J Brunswick and A Frazer
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 534-543;

  2. Fuhrman-Lane, C

    1. Trans-stilbene oxide administration increased hepatic glucuronidation of morphine but decreased biliary excretion of morphine glucuronide in rats.
      C Fuhrman-Lane and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 526-533;

  3. Fujimoto, J M

    1. Trans-stilbene oxide administration increased hepatic glucuronidation of morphine but decreased biliary excretion of morphine glucuronide in rats.
      C Fuhrman-Lane and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 526-533;

G

  1. Gerber, J G

    1. Beta adrenergically mediated release of renin in the dog is not confined to either beta-1 or beta-2 adrenoceptors.
      R D Olson, A S Nies and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 606-611;

  2. Gibson, G E

    1. 3,4-diaminopyridine alters acetylcholine metabolism and behavior during hypoxia.
      C Peterson and G E Gibson
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 576-582;

  3. Gioannini, T L

    1. Solubilization and characterization of active opiate binding sites from mammalian brain.
      R D Howells, T L Gioannini, J M Hiller and E J Simon
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 629-634;

  4. Gomeni, R

    1. Pharmacological evidence favoring a similarity between alpha adrenoceptors mediating sleep in chicks and cardiac presynaptic alpha-2 receptors in rats.
      A G Roach, F Lefèvre-Borg, R Gomeni and I Cavero
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 680-687;

  5. Gormley, J M

    1. Inhibition of high affinity choline uptake in the hippocampus: studies on the site of pentobarbital action.
      J A Richter and J M Gormley
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 778-785;

  6. Grignolo, A

    1. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, A Grignolo, W L Whitmore, L Lerea, P A Trepanier, G A Barnes, S J Weigel, F J Seidler and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 746-751;

  7. Gross, G J

    1. Role of autoregulation in the beneficial action of propranolol on ischemic blood flow distribution and stenosis severity in the canine myocardium.
      G J Gross, J D Buck, D C Warltier and H F Hardman
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 635-640;

H

  1. Haigler, H J

    1. Characteristics of adrenoceptors in a nociceptive pathway in the mesencephalic reticular formation of the rat.
      T P O'Neill and H J Haigler
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 555-561;

  2. Harden, T K

    1. Identification of the beta adrenergic receptor subtype on astroglia purified from rat brain.
      T K Harden and K D McCarthy
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 600-605;

  3. Hardman, H F

    1. Role of autoregulation in the beneficial action of propranolol on ischemic blood flow distribution and stenosis severity in the canine myocardium.
      G J Gross, J D Buck, D C Warltier and H F Hardman
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 635-640;

  4. Heydorn, W E

    1. Effect of treatment of rats with antidepressants on melatonin concentrations in the pineal gland and serum.
      W E Heydorn, D J Brunswick and A Frazer
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 534-543;

  5. Higuchi, M

    1. Effects of nitroglycerin on transmural energy metabolism in the underperfused canine heart.
      M Higuchi
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 694-698;

  6. Hiller, J M

    1. Solubilization and characterization of active opiate binding sites from mammalian brain.
      R D Howells, T L Gioannini, J M Hiller and E J Simon
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 629-634;

  7. Hirschowitz, B I

    1. Analysis of the 2-deoxy-D-glucose-induced vagal stimulation of gastric secretion and gastrin release in dogs using methionine-enkephalin, morphine and naloxone.
      W Anderson, E Molina, J Rentz and B I Hirschowitz
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 617-622;

  8. Hollinger, M A

    1. Biochemical evidence for pulmonary endothelial cell injury after carbon tetrachloride administration in mice.
      M A Hollinger
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 641-644;

  9. Holtzman, J L

    1. The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats.
      M Tsuru, R R Erickson and J L Holtzman
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 658-661;

  10. Homma, T

    1. Effect of prostaglandins on pancreatic circulation in anesthetized dogs.
      T Homma and K U Malik
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 623-628;

  11. Hong, S M

    1. Competitive inhibition of 48/80-induced histamine release by benzalkonium chloride and its analogs and the polyamine receptor in mast cells.
      G W Read, S M Hong and E F Kiefer
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 652-657;

  12. Howells, R D

    1. Solubilization and characterization of active opiate binding sites from mammalian brain.
      R D Howells, T L Gioannini, J M Hiller and E J Simon
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 629-634;

I

  1. Ichihara, K

    1. Effect of diltiazem, a calcium antagonist, on myocardial pH in ischemic canine heart.
      K Ichihara and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 720-725;

  2. Ijichi, H

    1. Central vasopressor responses to conjugated estrogens in rats may be mediated via a renin-angiotensin system in the brain.
      H Takahashi, H Ashizawa, K U Takeda, S Yoneda, M Yoshimura and H Ijichi
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 726-730;

  3. Izazola-Conde, C

    1. Evidence for the existence of peptide and nonpeptide morphine-like materials in mouse brain: effect of an analgesic intracerebroventricular dose of acetylcholine on their levels.
      T T Chau, C Izazola-Conde and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 612-616;

J

  1. Jobe, P C

    1. Effect of increments in norepinephrine concentrations on seizure intensity in the genetically epilepsy-prone rat.
      K H Ko, J W Dailey and P C Jobe
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 662-669;

K

  1. Kalsner, S

    1. Termination of responses to sympathetic nerve stimulation and to noradrenaline in a perfused arterial preparation: the role of neuronal and extraneuronal uptake.
      C C Chan and S Kalsner
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 731-740;

  2. Kenakin, T P

    1. The potentiation of cardiac responses to adenosine by benzodiazepines.
      T P Kenakin
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 752-758;

  3. Kendall, D A

    1. Influence of adrenocorticotropin hormone and yohimbine on antidepressant-induced declines in rat brain neurotransmitter receptor binding and function.
      D A Kendall, R Duman, J Slopis and S J Enna
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 566-571;

  4. Kennedy, C D

    1. Cerebral blood vessels: effects of exogenous acetylcholine and field stimulation on norepinephrine release.
      S P Duckles and C D Kennedy
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 562-565;

  5. Kiefer, E F

    1. Competitive inhibition of 48/80-induced histamine release by benzalkonium chloride and its analogs and the polyamine receptor in mast cells.
      G W Read, S M Hong and E F Kiefer
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 652-657;

  6. Ko, K H

    1. Effect of increments in norepinephrine concentrations on seizure intensity in the genetically epilepsy-prone rat.
      K H Ko, J W Dailey and P C Jobe
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 662-669;

  7. Kream, R M

    1. Evidence for the presynaptic localization of a high affinity opiate binding site on dopamine neurons in the pedal ganglia of Mytilus edulis (Bivalvia).
      G B Stefano, R S Zukin and R M Kream
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 759-764;

L

  1. Lalley, P M

    1. Inhibition of respiratory neural discharges by clonidine and 5-hydroxytryptophan.
      D R McCrimmon and P M Lalley
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 771-777;

  2. Lefèvre-Borg, F

    1. Pharmacological evidence favoring a similarity between alpha adrenoceptors mediating sleep in chicks and cardiac presynaptic alpha-2 receptors in rats.
      A G Roach, F Lefèvre-Borg, R Gomeni and I Cavero
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 680-687;

  3. Lerea, L

    1. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, A Grignolo, W L Whitmore, L Lerea, P A Trepanier, G A Barnes, S J Weigel, F J Seidler and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 746-751;
    2. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, F J Seidler, P A Trepanier, W L Whitmore, L Lerea, G A Barnes, S J Weigel and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 741-745;

M

  1. Malik, K U

    1. Effect of prostaglandins on pancreatic circulation in anesthetized dogs.
      T Homma and K U Malik
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 623-628;

  2. Mandel, H G

    1. Effects of DNA synthesis inhibitors on post-traumatic glial cell proliferation.
      M L Billingsley and H G Mandel
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 765-770;

  3. Maynard, J R

    1. Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.
      D J Crutchley, L B Conanan and J R Maynard
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 544-549;

  4. McCarthy, K D

    1. Identification of the beta adrenergic receptor subtype on astroglia purified from rat brain.
      T K Harden and K D McCarthy
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 600-605;

  5. McCrimmon, D R

    1. Inhibition of respiratory neural discharges by clonidine and 5-hydroxytryptophan.
      D R McCrimmon and P M Lalley
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 771-777;

  6. McNamara, J O

    1. Kindled seizures selectively reduce a subpopulation of [3H]quinuclidinyl benzilate binding sites in rat dentate gyrus.
      D D Savage and J O McNamara
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 670-673;

  7. Mitch, W E

    1. Benzoate-induced changes in glycine and urea metabolism in patients with chronic renal failure.
      W E Mitch and S Brusilow
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 572-575;

  8. Molina, E

    1. Analysis of the 2-deoxy-D-glucose-induced vagal stimulation of gastric secretion and gastrin release in dogs using methionine-enkephalin, morphine and naloxone.
      W Anderson, E Molina, J Rentz and B I Hirschowitz
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 617-622;

  9. Murray, T F

    1. Inhibition of acetylcholine turnover rate in rat hippocampus and cortex by intraventricular injection of adenosine analogs.
      T F Murray, W D Blaker, D L Cheney and E Costa
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 550-554;

N

  1. Nies, A S

    1. Beta adrenergically mediated release of renin in the dog is not confined to either beta-1 or beta-2 adrenoceptors.
      R D Olson, A S Nies and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 606-611;

O

  1. O'Neill, T P

    1. Characteristics of adrenoceptors in a nociceptive pathway in the mesencephalic reticular formation of the rat.
      T P O'Neill and H J Haigler
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 555-561;

  2. Olson, R D

    1. Beta adrenergically mediated release of renin in the dog is not confined to either beta-1 or beta-2 adrenoceptors.
      R D Olson, A S Nies and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 606-611;

P

  1. Paire, M

    1. Mechanism of action of quinidine on heart rate in the dog.
      C Chassaing, P Duchene-Marullaz and M Paire
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 688-693;

  2. Peterson, C

    1. 3,4-diaminopyridine alters acetylcholine metabolism and behavior during hypoxia.
      C Peterson and G E Gibson
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 576-582;

  3. Prozialeck, W C

    1. Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships.
      W C Prozialeck and B Weiss
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 509-516;

R

  1. Read, G W

    1. Competitive inhibition of 48/80-induced histamine release by benzalkonium chloride and its analogs and the polyamine receptor in mast cells.
      G W Read, S M Hong and E F Kiefer
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 652-657;

  2. Reilly, M A

    1. Suppression of histamine-induced adrenocorticotropic hormone release by antihistamines and antidepressants.
      M A Reilly and E B Sigg
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 583-588;

  3. Rentz, J

    1. Analysis of the 2-deoxy-D-glucose-induced vagal stimulation of gastric secretion and gastrin release in dogs using methionine-enkephalin, morphine and naloxone.
      W Anderson, E Molina, J Rentz and B I Hirschowitz
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 617-622;

  4. Richter, J A

    1. Inhibition of high affinity choline uptake in the hippocampus: studies on the site of pentobarbital action.
      J A Richter and J M Gormley
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 778-785;

  5. Roach, A G

    1. Pharmacological evidence favoring a similarity between alpha adrenoceptors mediating sleep in chicks and cardiac presynaptic alpha-2 receptors in rats.
      A G Roach, F Lefèvre-Borg, R Gomeni and I Cavero
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 680-687;

  6. Rodgers, K

    1. Chelation of cadmium from metallothionein in vivo and its excretion in rats repeatedly injected with cadmium chloride.
      M G Cherian and K Rodgers
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 699-704;

  7. Ruffolo, R R

    1. Stereochemical requirements of alpha-2 adrenergic receptors.
      R R Ruffolo, E L Yaden and J E Waddell
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 645-651;

S

  1. Savage, D D

    1. Kindled seizures selectively reduce a subpopulation of [3H]quinuclidinyl benzilate binding sites in rat dentate gyrus.
      D D Savage and J O McNamara
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 670-673;

  2. Seidler, F J

    1. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, A Grignolo, W L Whitmore, L Lerea, P A Trepanier, G A Barnes, S J Weigel, F J Seidler and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 746-751;
    2. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, F J Seidler, P A Trepanier, W L Whitmore, L Lerea, G A Barnes, S J Weigel and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 741-745;

  3. Sigg, E B

    1. Suppression of histamine-induced adrenocorticotropic hormone release by antihistamines and antidepressants.
      M A Reilly and E B Sigg
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 583-588;

  4. Simon, E J

    1. Solubilization and characterization of active opiate binding sites from mammalian brain.
      R D Howells, T L Gioannini, J M Hiller and E J Simon
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 629-634;

  5. Slopis, J

    1. Influence of adrenocorticotropin hormone and yohimbine on antidepressant-induced declines in rat brain neurotransmitter receptor binding and function.
      D A Kendall, R Duman, J Slopis and S J Enna
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 566-571;

  6. Slotkin, T A

    1. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, A Grignolo, W L Whitmore, L Lerea, P A Trepanier, G A Barnes, S J Weigel, F J Seidler and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 746-751;
    2. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, F J Seidler, P A Trepanier, W L Whitmore, L Lerea, G A Barnes, S J Weigel and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 741-745;

  7. Stefano, G B

    1. Evidence for the presynaptic localization of a high affinity opiate binding site on dopamine neurons in the pedal ganglia of Mytilus edulis (Bivalvia).
      G B Stefano, R S Zukin and R M Kream
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 759-764;

T

  1. Takahashi, H

    1. Central vasopressor responses to conjugated estrogens in rats may be mediated via a renin-angiotensin system in the brain.
      H Takahashi, H Ashizawa, K U Takeda, S Yoneda, M Yoshimura and H Ijichi
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 726-730;

  2. Takeda, K U

    1. Central vasopressor responses to conjugated estrogens in rats may be mediated via a renin-angiotensin system in the brain.
      H Takahashi, H Ashizawa, K U Takeda, S Yoneda, M Yoshimura and H Ijichi
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 726-730;

  3. Taylor, D G

    1. Pharmacological studies on sympathoinhibition produced by the medial medullary depressor region: proposed gamma-aminobutyric acid involvement in inhibition of somatosympathetic reflexes.
      D G Taylor, K A Taylor and M J Antonaccio
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 517-525;

  4. Taylor, K A

    1. Pharmacological studies on sympathoinhibition produced by the medial medullary depressor region: proposed gamma-aminobutyric acid involvement in inhibition of somatosympathetic reflexes.
      D G Taylor, K A Taylor and M J Antonaccio
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 517-525;

  5. Timmermans, P B

    1. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. I. Central hypotensive and peripheral hypertensive activities.
      A de Jonge, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 705-711;
    2. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. II. Central and peripheral bradycardic activities.
      A de Jonge, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 712-719;

  6. Trepanier, P A

    1. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, A Grignolo, W L Whitmore, L Lerea, P A Trepanier, G A Barnes, S J Weigel, F J Seidler and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 746-751;
    2. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, F J Seidler, P A Trepanier, W L Whitmore, L Lerea, G A Barnes, S J Weigel and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 741-745;

  7. Tsuru, M

    1. The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats.
      M Tsuru, R R Erickson and J L Holtzman
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 658-661;

V

  1. van Zwieten, P A

    1. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. I. Central hypotensive and peripheral hypertensive activities.
      A de Jonge, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 705-711;
    2. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. II. Central and peripheral bradycardic activities.
      A de Jonge, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 712-719;

W

  1. Waddell, J E

    1. Stereochemical requirements of alpha-2 adrenergic receptors.
      R R Ruffolo, E L Yaden and J E Waddell
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 645-651;

  2. Warltier, D C

    1. Role of autoregulation in the beneficial action of propranolol on ischemic blood flow distribution and stenosis severity in the canine myocardium.
      G J Gross, J D Buck, D C Warltier and H F Hardman
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 635-640;

  3. Weigel, S J

    1. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, A Grignolo, W L Whitmore, L Lerea, P A Trepanier, G A Barnes, S J Weigel, F J Seidler and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 746-751;
    2. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, F J Seidler, P A Trepanier, W L Whitmore, L Lerea, G A Barnes, S J Weigel and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 741-745;

  4. Weiss, B

    1. Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships.
      W C Prozialeck and B Weiss
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 509-516;

  5. Whitmore, W L

    1. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, A Grignolo, W L Whitmore, L Lerea, P A Trepanier, G A Barnes, S J Weigel, F J Seidler and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 746-751;
    2. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
      T A Slotkin, F J Seidler, P A Trepanier, W L Whitmore, L Lerea, G A Barnes, S J Weigel and J Bartolome
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 741-745;

  6. Wood, P L

    1. Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat.
      P L Wood
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 674-679;

Y

  1. Yaden, E L

    1. Stereochemical requirements of alpha-2 adrenergic receptors.
      R R Ruffolo, E L Yaden and J E Waddell
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 645-651;

  2. Yoneda, S

    1. Central vasopressor responses to conjugated estrogens in rats may be mediated via a renin-angiotensin system in the brain.
      H Takahashi, H Ashizawa, K U Takeda, S Yoneda, M Yoshimura and H Ijichi
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 726-730;

  3. Yoshimura, M

    1. Central vasopressor responses to conjugated estrogens in rats may be mediated via a renin-angiotensin system in the brain.
      H Takahashi, H Ashizawa, K U Takeda, S Yoneda, M Yoshimura and H Ijichi
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 726-730;

Z

  1. Zukin, R S

    1. Evidence for the presynaptic localization of a high affinity opiate binding site on dopamine neurons in the pedal ganglia of Mytilus edulis (Bivalvia).
      G B Stefano, R S Zukin and R M Kream
      Journal of Pharmacology and Experimental Therapeutics September 1982, 222 (3) 759-764;
Back to top

In this issue

Advertisement